一种包含Ki67的诺米图,用于预测状黑色素瘤的存活率
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, No. 52 Fucheng Road, Haidian District, Beijing, 100142, China.
Journal of cancer research and clinical oncology
|July 20, 2023
概括
基67表达是状黑色素瘤 (AM) 存活率的显著预后因素. 包括Ki67在内的新预测模型改善了与传统分期相比的预后预测.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 癌症研究 癌症研究
背景情况:
- Ki67是一种已知的增殖标志物,与黑色素瘤进展有关.
- 具体而言,Ki67在状黑色素瘤 (AM) 的预后价值以前尚不清楚.
研究的目的:
- 为了研究Ki67表达在状黑色素瘤的预后影响.
- 开发一个AM生存的预测模型,结合Ki67.7.
主要方法:
- 对314名状黑色素瘤患者的回顾性分析.
- 分类为高基67 (≥30%) 和低基67组.
- 考克斯回归分析和名图构造用于生存预测.
主要成果:
- 高基67表达与显著较低的黑色素瘤特异性存活率 (MSS) 有关.
- Ki67,淋巴结转移和主要部位是MSS的独立预后因素.
- 开发的诺米图表表现出比AJCC分期系统更好的预测性能.
结论:
- 基67表达是状黑色素瘤的独立预后指标.
- 结合Ki67和临床因素的新型预测模型增强了AM预后评估.
相关概念视频
01:21Cancer Survival Analysis
390
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
390
01:24Kaplan-Meier Approach
183
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
183